GoHealth Inc.
$ 1.09
1.87%
15 Apr - close price
- Market Cap 30,865,400 USD
- Current Price $ 1.09
- High / Low $ 1.15 / 1.05
- Stock P/E N/A
- Book Value 2.34
- EPS -20.17
- Next Earning Report f
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.08 %
- ROE -2.20 %
- 52 Week High 11.36
- 52 Week Low 1.00
About
GoHealth, Inc. is a health insurance marketplace and a Medicare-focused digital health company in the United States. The company is headquartered in Chicago, Illinois.
Analyst Target Price
$4.70
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-01 | 2025-12-31 | 2025-11-13 | 2025-08-12 | 2025-05-07 | 2025-03-12 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-09 | 2023-08-10 |
| Reported EPS | -2.0754 | -1.03 | -11.8 | -5.1 | -0.52 | 1.56 | 0.46 | -2.27 | -1.04 | -0.22 | -2.61 | -3.27 |
| Estimated EPS | None | -2.0929 | -2.36 | -2.13 | -0.3325 | 0.968 | -3.19 | -2.47 | -0.95 | 2.73 | -2.9 | -2.92 |
| Surprise | 0 | 1.0629 | -9.44 | -2.97 | -0.1875 | 0.592 | 3.65 | 0.2 | -0.09 | -2.95 | 0.29 | -0.35 |
| Surprise Percentage | None% | 50.786% | -400% | -139.4366% | -56.391% | 61.157% | 114.4201% | 8.0972% | -9.4737% | -108.0586% | 10% | -11.9863% |
Next Quarterly Earnings
| Apr 2026 | |
|---|---|
| Reported Date | f |
| Fiscal Date Ending | o |
| Estimated EPS | r |
| Currency | m |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: GOCO
2026-04-13 12:39:34
The Portnoy Law Firm has announced an investigation into potential securities fraud involving GoHealth, Inc. (NASDAQ: GOCO). This investigation follows a significant drop in GoHealth's stock price after the U.S. Department of Justice filed a False Claims Act complaint, alleging that GoHealth and other insurers engaged in illegal kickbacks to brokers for Medicare Advantage plan enrollments between 2016 and 2021. Investors are encouraged to contact the law firm for a complimentary case evaluation regarding their losses.
2026-04-13 12:38:55
The Portnoy Law Firm has launched an investigation into potential securities fraud involving GoHealth, Inc. (NASDAQ: GOCO) following a significant drop in its stock price. This investigation stems from a False Claims Act complaint filed by the U.S. Department of Justice, alleging that GoHealth and other health insurers engaged in illegal kickbacks to brokers. Investors are encouraged to contact the law firm to discuss their legal rights and potential for recovering losses.
2026-04-03 23:40:19
GoHealth Inc. (GOCO) reported its FY2025 financial results, with net revenue of $361.85 million, exceeding analyst estimates, but a GAAP loss per share of $(20.17), significantly lower than anticipated. The company's revenue declined 54.7% year-over-year, primarily due to an intentional pullback in Medicare Advantage activity and substantial impairment charges. Management emphasized a strategic shift towards consumer fit, renewal economics, and cash discipline in a challenging Medicare Advantage market.
2026-04-03 17:39:01
GoHealth (GOCO) reported its FY2025 financial results, with a net revenue of $361.85 million, exceeding analyst estimates, but a GAAP loss per share of $(20.17), falling below expectations due to significant impairment charges. The company experienced a 54.7% year-over-year decline in net revenue and a net loss of $497.76 million, primarily driven by a deliberate pullback in Medicare Advantage activity and a challenging market environment. Management emphasized a focus on consumer fit, retention, and cash discipline, alongside efforts to reduce variable operating expenses.
2026-04-02 00:40:07
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. (NASDAQ:GOCO) following an announcement by the United States Department of Justice. The investigation stems from allegations that GoHealth was involved in unlawful kickbacks and discrimination against disabled Americans, leading to a significant drop in its stock price. Investors are encouraged to contact the firm for more information regarding this investigation.
2026-04-01 01:41:11
GoHealth, Inc. announced its full-year 2025 financial results, emphasizing a strategic shift in response to a changing Medicare Advantage market. The company focused on consumer-first enrollment, an intentional pullback from broader Medicare Advantage activities, and continued leadership in Special Needs Plans (SNP). GoHealth also highlighted its commitment to cash discipline, improving capital structure, and targeted investments in technology and AI to enhance efficiency and reduce acquisition costs.
